We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Sony
SONY
$123B
| $1.36M | 0.02% |
88,935
+61,110
| +220% | +$950K |
|
827
Tetra Tech
TTEK
$8.23B
| $1.36M | 0.02% |
71,325
-460,170
| -87% | -$8.18M |
|
828
Yelp
YELP
$1.38B
| $1.36M | 0.02% |
67,771
-1,934
| -3% | -$44K |
|
829
uniQure
QURE
$2.68B
| $1.36M | 0.02% |
+36,936
| New | +$1.51M |
|
830
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $1.36M | 0.02% |
4,894
-40,684
| -89% | -$11.1M |
|
831
Analog Devices
ADI
$181B
| $1.35M | 0.02% |
+11,569
| New | +$1.35M |
|
832
Glacier Bancorp
GBCI
$6.55B
| $1.34M | 0.02% |
41,890
+33,500
| +399% | +$1.16M |
|
|
LTHM
833
DELISTED
Livent Corporation
LTHM
| $1.34M | 0.02% |
+149,776
| New | +$1.13M |
|
834
Revvity
RVTY
$12.3B
| $1.34M | 0.02% |
+10,692
| New | +$1.23M |
|
|
SNBR
835
DELISTED
Sleep Number
SNBR
| $1.34M | 0.02% |
27,398
+15,211
| +125% | +$715K |
|
836
World Kinect Corp
WKC
$1.96B
| $1.34M | 0.02% |
63,216
+5,376
| +9% | +$132K |
|
|
BPMC
837
DELISTED
Blueprint Medicines
BPMC
| $1.34M | 0.02% |
14,426
-13,281
| -48% | -$1.02M |
|
838
The RealReal
REAL
$1.34B
| $1.34M | 0.02% |
+92,392
| New | +$1.41M |
|
839
CrowdStrike
CRWD
$187B
| $1.34M | 0.02% |
38,924
-1,005,412
| -96% | -$29.3M |
|
840
Neurocrine Biosciences
NBIX
$17.7B
| $1.33M | 0.02% |
+13,839
| New | +$1.6M |
|
|
HIBB
841
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.33M | 0.02% |
33,900
-12,375
| -27% | -$358K |
|
|
ZGNX
842
DELISTED
Zogenix, Inc.
ZGNX
| $1.33M | 0.02% |
73,976
-6,628
| -8% | -$162K |
|
|
RDFN
843
DELISTED
Redfin
RDFN
| $1.32M | 0.02% |
26,500
+558
| +2% | +$24.7K |
|
844
Ericsson
ERIC
$30.7B
| $1.32M | 0.02% |
+121,402
| New | +$1.34M |
|
845
The GEO Group
GEO
$4.13B
| $1.32M | 0.02% |
116,468
+28,650
| +33% | +$320K |
|
846
Donaldson
DCI
$10.8B
| $1.31M | 0.02% |
28,175
-65,386
| -70% | -$3.18M |
|
847
Mativ Holdings
MATV
$448M
| $1.31M | 0.02% |
+42,980
| New | +$1.35M |
|
848
Ryder
R
$10.3B
| $1.3M | 0.02% |
30,829
-42,177
| -58% | -$1.71M |
|
|
NSA
849
DELISTED
National Storage Affiliates Trust
NSA
| $1.3M | 0.02% |
39,749
+30,221
| +317% | +$971K |
|
850
Badger Meter
BMI
$3.66B
| $1.3M | 0.02% |
19,858
-5,232
| -21% | -$334K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.